[1] |
Wang Yihan, Qin Xuyan, Han Xuanze, Wang Yingjie, Gao Feifei, Chen Chunhong, Zhang Lingnan, Zhang Fang.
Efficacy and safety of rivaroxaban therapy in elderly patients with non-valvular atrial fibrillation who had a HASBLED score≥3
[J]. Clinical Focus, 2024, 39(2): 121-124.
|
[2] |
.
[J]. Clinical Focus, 2024, 39(2): 168-171.
|
[3] |
Zhang Fang, Zhang Yichao, Jia Xinwei, Li Jianlong, Chen Chunhong.
Analysis of one-year follow-up results of ≥75-year-old atrial fibrillation inpatients with high CHA2DS2-VASc score
[J]. Clinical Focus, 2023, 38(2): 117-120.
|
[4] |
Li Weiwei, Li Yanan.
Left atrial volume index predicts atrial fibrillation recurrence after radiofrequency ablation: A meta-analysis
[J]. Clinical Focus, 2022, 37(11): 965-968.
|
[5] |
An Jingjing, Wang Xiaojuan, Deng Aiyun.
Radiofrequency ablation in treating pre-excited atrial fibrillation recurrence: A meta analysis
[J]. Clinical Focus, 2022, 37(10): 899-904.
|
[6] |
.
[J]. Clinical Focus, 2022, 37(10): 946-949.
|
[7] |
Ma Jinghong, Yang Qian, Jia Yongjian, Dang Yi.
Risks of cardiac tamponade resulting from uninterrupted novel oral anticoagulants and uninterrupted warfarin during perioperative period of catheter ablation of atrial fibrillation: A meta-analysis
[J]. Clinical Focus, 2022, 37(9): 773-778.
|
[8] |
Zhang Haifu, Ye Xiangqing, Chen Zhexu, Chen Shijian, Yang Dong, Zhang Xingwei.
Effects of moderate exercise on the prognosis of patients with atrial fibrillation:A systematic review and Meta-analysis
[J]. Clinical Focus, 2022, 37(6): 485-489.
|
[9] |
Zhao Meili, Xiao Liyuan, Liu Lin, Kang Chao, Zhang Qiuxiang.
Correlation between NT-proBNP, hs-CRP, left atrium diameter and chronic heart failure concurrent with atrial fibrillation
[J]. Clinical Focus, 2021, 36(5): 412-415.
|
[10] |
Lu Yuqin, Li Yingdong, Liu Kai.
Role of serum MMP-1, MMP-3, TIMP-1 and Hcy levels in patients with hypertension complicated with atrial fibrillation
[J]. Clinical Focus, 2020, 35(11): 976-979.
|
[11] |
.
[J]. Clinical Focus, 2020, 35(11): 1030-1034.
|
[12] |
.
[J]. Clinical Focus, 2016, 31(2): 226-228.
|
[13] |
Guo Xueyuan, Ma Changsheng.
Atrial fibrillation treatment: present state and future directions
[J]. Clinical Focus, 2016, 31(1): 7-9.
|
[14] |
Qi Shuyuan,Tian Ying.
Role of percutaneous left atrial appendage occlusion in stroke prevention for nonvalvular atrial fibrillation
[J]. Clinical Focus, 2016, 31(1): 10-13.
|
[15] |
Xue Li, Cai Heng.
Anticoagulation advance in atrial fibrillation
[J]. Clinical Focus, 2016, 31(1): 14-18.
|